157 related articles for article (PubMed ID: 32231227)
1. Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial.
Botana-Rial M; Vázquez-Iglesias L; Casado-Rey P; Cadena MP; Andrade-Olivié MA; Abal-Arca J; García-Nimo L; Ferreiro-Fernández L; Valdés-Cuadrado L; San-José ME; Rodríguez-Berrocal FJ; Fernández-Villar A
Sci Rep; 2020 Mar; 10(1):5679. PubMed ID: 32231227
[TBL] [Abstract][Full Text] [Related]
2. Calprotectin: a novel biomarker for the diagnosis of pleural effusion.
Sánchez-Otero N; Blanco-Prieto S; Páez de la Cadena M; Vázquez-Iglesias L; Fernández-Villar A; Botana-Rial MI; Rodríguez-Berrocal FJ
Br J Cancer; 2012 Nov; 107(11):1876-82. PubMed ID: 23093228
[TBL] [Abstract][Full Text] [Related]
3. A Novel Combination of Calprotectin and CXCL12 for Predicting Malignancy in Patients with Exudative Pleural Effusion.
Luo J; Wang M; Li C; Liang B; Liu D; Shi C; Jiang F; Wang T; Li P; Liang Z
Medicine (Baltimore); 2015 Nov; 94(47):e2105. PubMed ID: 26632726
[TBL] [Abstract][Full Text] [Related]
4. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
5. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.
Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A
Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016
[No Abstract] [Full Text] [Related]
6. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
7. A rapid calprotectin test for the diagnosis of pleural effusion.
Casado-Rey P; Vázquez-Iglesias L; Botana-Rial M; Andrade-Olivié MA; Ferreiro-Fernández L; San José Capilla E; Nuñez-Ares A; Bollo de Miguel E; Pajares-Ruíz V; Fernández-Villar A
PLoS One; 2021; 16(6):e0252714. PubMed ID: 34111153
[TBL] [Abstract][Full Text] [Related]
8. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.
Botana-Rial M; Casado-Rey P; Leiro-Fernández V; Andrade-Olivié M; Represas-Represas C; Fernández-Villar A
Clin Lab; 2011; 57(5-6):373-8. PubMed ID: 21755828
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of periostin in lung cancer-related malignant pleural effusion.
Zhang J; Zha T; Zhang N; Sun G
J Clin Lab Anal; 2022 Feb; 36(2):e24179. PubMed ID: 35152510
[TBL] [Abstract][Full Text] [Related]
11. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.
Choi H; Ko Y; Lee CY
BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a machine learning model for differential diagnosis of malignant pleural effusion using routine laboratory data.
Wei TT; Zhang JF; Cheng Z; Jiang L; Li JY; Zhou L
Ther Adv Respir Dis; 2023; 17():17534666231208632. PubMed ID: 37941347
[TBL] [Abstract][Full Text] [Related]
13. Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.
Chantharakhit C; Sujaritvanichpong N
Asian Pac J Cancer Prev; 2022 Jan; 23(1):25-31. PubMed ID: 35092368
[TBL] [Abstract][Full Text] [Related]
14. Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.
Zhu J; Feng M; Liang L; Zeng N; Wan C; Yang T; Shen Y; Wen F
BMC Cancer; 2017 Aug; 17(1):590. PubMed ID: 28854885
[TBL] [Abstract][Full Text] [Related]
15. Differences in
Xie T; Wang Q; Gao J; He K; Yu J
Ann Clin Lab Sci; 2024 Mar; 54(2):201-210. PubMed ID: 38802158
[TBL] [Abstract][Full Text] [Related]
16. Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.
Zhang H; Li C; Hu F; Zhang X; Shen Y; Chen Y; Li F
Respir Res; 2020 Oct; 21(1):284. PubMed ID: 33121490
[TBL] [Abstract][Full Text] [Related]
17. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
[TBL] [Abstract][Full Text] [Related]
18. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
Tian T; Li J; Hu W; Sun C; Zhou J
J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
Zhu LR; Yuan RX; Xia XB; Wang Y; Zhu YM; Fi L; Li J
Cancer Biomark; 2022; 33(1):71-82. PubMed ID: 34366325
[TBL] [Abstract][Full Text] [Related]
20. The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion.
Fiorelli A; Morgillo F; Fasano M; Vicidomini G; Di Crescenzo VG; Di Domenico M; Accardo M; Santini M
Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):263-9. PubMed ID: 23190621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]